Latest filing published 14 Oct 2026 for Centrica plc, €214.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Russell O'Brien appears in our data through filings on Centrica plc shares, published by RNS (LSE). We count 64 filings; the first trade dates from 12 June 2023 and the latest from 12 October 2026.
Both buying and selling appear: 5 purchases worth €1.3M, against 1 sale. The amount is not disclosed for 1 filing. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 58 share grants. In 2026 alone, the filings show 3 purchases and 1 sale.
A typical purchase (the median) is worth €371k. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
On 14 October 2026 came the latest disclosure, a share grant for €214 in Centrica plc. The latest purchase dates back some time: it was published 32 days ago, on 21 September 2026. The median gap between a trade and its publication by RNS (LSE) is 1 day. The legal deadline for notifying a trade is three business days (UK MAR). This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 63 declarations